7ZYU image
Entry Detail
PDB ID:
7ZYU
Keywords:
Title:
HDAC6 ZnF domain inhibitor - DARPin (Designed Ankyrin repeat protein) F10
Biological Source:
PDB Version:
Deposition Date:
2022-05-25
Release Date:
2022-06-01
Method Details:
Experimental Method:
Resolution:
2.43 Å
R-Value Free:
0.24
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Histone deacetylase 6
Chain IDs:A
Chain Length:110
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Designed Ankyrin repeat protein F10
Chain IDs:B
Chain Length:162
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways.
Cell Rep 39 110736 110736 (2022)
PMID: 35476995 DOI: 10.1016/j.celrep.2022.110736

Abstact

The deacetylase HDAC6 has tandem catalytic domains and a zinc finger domain (ZnF) binding ubiquitin (Ub). While the catalytic domain has an antiviral effect, the ZnF facilitates influenza A virus (IAV) infection and cellular stress responses. By recruiting Ub via the ZnF, HDAC6 promotes the formation of aggresomes and stress granules (SGs), dynamic structures associated with pathologies such as neurodegeneration. IAV subverts the aggresome/HDAC6 pathway to facilitate capsid uncoating during early infection. To target this pathway, we generate designed ankyrin repeat proteins (DARPins) binding the ZnF; one of these prevents interaction with Ub in vitro and in cells. Crystallographic analysis shows that it blocks the ZnF pocket where Ub engages. Conditional expression of this DARPin reversibly impairs infection by IAV and Zika virus; moreover, SGs and aggresomes are downregulated. These results validate the HDAC6 ZnF as an attractive target for drug discovery.

Legend

Protein

Chemical

Disease

Primary Citation of related structures